Randomized, double-blind, active-controlled, multicentre, phase III clinical trial with two stages to assess the safety and efficacy of letibotulinum toxin a vs. onabotulinum toxin a for subjects with moderate to severe crow's feet.

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)

This study showed that LeBA was as effective and safe as OnBA for the treatment of CFL at the same doses.

Keyphrases